Clinical Trial Update: Tongjiang Series Prescription Combined With PPIs Descending Ladder Withdrawal in Treating Nonerosive Reflux Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Tongjiang series prescription with PPIs for nonerosive reflux disease; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonerosive Reflux Disease

Drugs mentioned

• PPIs
• Tongjiang series prescription

Snippet

Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences | Conditions: Nonerosive Reflux Disease | Phase 3 | Status: UNKNOWN